Table 3.
No Diabetes | Diabetes | p-value interaction | |||
---|---|---|---|---|---|
1987–1996 | 2003–2009 | 1987–1996 | 2003–2009 | ||
N | 13,152 | 10,415 | 1,673 | 2,297 | |
CHD incidence | |||||
Incidence rate* (95% CI) | 3.9 (3.5, 4.4) | 2.2 (1.8, 2.7) | 11.1 (9.3, 13.2) | 5.4 (4.2, 7.0) | --- |
Model 1† | 1 (ref) | 0.60 (0.48, 0.76) | 1 (ref) | 0.53 (0.38, 0.73) | 0.39 |
Model 2‡ | 1 (ref) | 0.64 (0.50, 0.80) | 1 (ref) | 0.56 (0.40, 0.78) | 0.33 |
Model 3§ | 1 (ref) | 0.75 (0.59, 0.96) | 1 (ref) | 0.68 (0.46, 0.99) | 0.95 |
CHD mortality | |||||
Mortality rate* (95% CI) | 0.8 (0.7, 1.1) | 0.4 (0.3, 0.6) | 4.3 (3.2, 5.7) | 1.3 (0.9, 1.9) | --- |
Model 1† | 1 (ref) | 0.49 (0.32, 0.76) | 1 (ref) | 0.32 (0.20, 0.52) | 0.09 |
Model 2‡ | 1 (ref) | 0.55 (0.36, 0.85) | 1 (ref) | 0.34 (0.20, 0.56) | 0.08 |
Model 3§ | 1 (ref) | 0.64 (0.40, 1.00) | 1 (ref) | 0.45 (0.26, 0.80) | 0.21 |
CHD: coronary heart disease; CI: confidence interval; p-value for interaction of diabetes status and time period
Rates are per 1,000 person-years and adjusted for age, race, and sex
Model 1: adjusted for age, race, and sex
Model 2: adjusted for age, race, sex, high-density lipoprotein cholesterol, systolic blood pressure, antihypertensive medication use, current smoking, and body mass index
Model 3: adjusted for model 2 variables plus lipid-lowering medication use and low-density lipoprotein cholesterol